Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cell-free DNA Methylation Liquid Biopsy for Diagnosis and Management of Biliary Tract Cancers

NCT07176962 is registered in ClinicalTrials.gov with Yingbin Liu, MD, PhD, FACS as lead sponsor.

NCT NCT07176962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07176962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cell-free DNA Methylation Liquid Biopsy for Diagnosis and Management of Biliary Tract Cancers
Lead sponsor
Yingbin Liu, MD, PhD, FACS
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2020
Completion date
May 1, 2026
Enrollment
1,800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

billiary track cancer, ctdna, extrahepatic cholangiocarcinoma, gall bladder cancer, hilar cholangiocarcinoma, intrahepatic cholangiocarcinoma (icc)